PHB2 and HSP90AB1 were overexpressed in the metastatic tumors compared with LUAD primary tumors, and high level of HSP90AB1 predicted shorter overall survival and first progression times of LUAD patients (Supplementary Fig. 2B and 2 C) [36]. Here, HSP90AB1 is linked to metastatic neoplasm.